checkAd

     123  0 Kommentare Inozyme Pharma Appoints Yves Sabbagh, Ph.D., as Senior Vice President and Chief Scientific Officer - Seite 3

    Investors:
    Brian Luque, Director, Investor Relations
    (951) 206-1200
    ir@inozyme.com

    Lesen Sie auch

    Media:
    Alex Van Rees, SmithSolve
    (973) 442-1555 ext. 111
    alex.vanrees@smithsolve.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Inozyme Pharma Appoints Yves Sabbagh, Ph.D., as Senior Vice President and Chief Scientific Officer - Seite 3 – Dr. Sabbagh Brings More Than 20 Years of Experience in Rare Genetic Disorders and Mineral Metabolism Research Development Programs – – Company Announces Retirement of David Thompson, Ph.D. – – Company to Open New Laboratory Space to Increase …